- citati u SCIndeksu:
0
- citati u CrossRef-u:[1]
- citati u Google Scholaru:[
]
- posete u poslednjih 30 dana:0
- preuzimanja u poslednjih 30 dana:0
|
|
2023, vol. 42, br. 3, str. 476-483
|
LncRNA CASC11 pogoršava dijabetičku nefropatiju ciljanjem FoxO1
Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1
Second Affiliated Hospital of Fujian Medical University, Department of Renal Medicine, Quanzhou, China
e-adresa: [email protected]
Projekat: Natural Science Foundation of Fujian Province (2021J01250)
Ključne reči: dijabetička nefropatija (DN); CASC11; FoxO1; TGF-b1/Smads
Keywords: Diabetic nephropathy (DN); CASC11; FoxO1; TGF-b1/Smads
Sažetak
Uvod: Cilj je bio da se istraži biološki efekat CASC11 na pogoršanje dijabetičke nefropatije (DN) regulacijom FoxO1 (faktor transkripcije viljuške O1). Metode: Detektovani su nivoi CASC11 i FoxO1 u serumu kod pacijenata sa DN. Mogućnost CASC11 u predviđanju početka DN analizirana je prikazivanjem ROC krivih. Korelacija između CASC11 i FoxO1 je procenjena Pirsonovim korelacionim testom. Nakon intervenisanja nivoa CASC11 i FoxO1, otkrili smo da su određene promene u proliferativnim i migratornim sposobnostima u mezangijalnim ćelijama bubrega izazvanim visokom glukozom (HG). Nivoi proteina TGF-b1 i Smads regulisani i CASC11 i FoxO1 su ispitani Vestern blotom. Rezultati: Visoka ekspresija CASC11, ali niska ekspresija FoxO1 bili su u serumu pacijenata sa DN, što pokazuje da su negativna korelacija. Dakle, CASC11 može biti dijagnostički marker za DN. On je oslabio proliferativne i migratorne sposobnosti mezangijalnih ćelija bubrega izazvanih HG, ali gornji inhibitorni efekti CASC11 mogu se ukinuti prekomernom ekspresijom FoxO1. Osim toga, nivoi proteina TGF-b1 i Smads-a su pozitivno regulisani od strane CASC11, ali je regulacija Smads-a preokrenula takve promene. Zaključak: Kroz aktiviranje TGF-b1/Smads signalizacije, CASC11 inhibira ekspresiju FoxO1 i na taj način indukuje pogoršanje DN.
Abstract
Background: To explore the biological effects of CASC11 on aggravating diabetic nephropathy (DN) by regulating FoxO1 (forkhead transcription factor O1). Methods: Serum levels of CASC11 and FoxO1 in DN patients were detected. The possibility of CASC11 in predicting the onset of DN was analyzed by depicting ROC curves. Correlation between CASC11 and FoxO1 was evaluated by Pearson correlation test. After intervening CASC11 and FoxO1 levels, we found that changes in proliferative and migratory abilities in high glucose (HG)induced kidney mesangial cells were determined respectively. Protein levels of TGF-b1 and Smads regulated by both CASC11 and FoxO1 were examined by Western blot. Results: A high expression CASC11 but a low expression of FoxO1were in serum of DN patients, showing they were a negative correlation. Hence, CASC11 may be a diagnostic marker for DN. It attenuated proliferative and migratory abilities of HG-induced kidney mesangial cells, but the above inhibitory effects of CASC11 could be abolished by overexpression of FoxO1. Besides, protein levels of TGF-b1 and Smads were positively regulated by CASC11, but Smads regulation were reversed such changes. Conclusion: Through activating the TGF-b1/Smads signaling, CASC11 inhibits FoxO1 expression and thus induces the aggravation of DN.
IntroductionDiabetic nephropathy (DN) is one of the most
serious comorbidities in diabetes patients, which is
also a main cause of diabetes-induced death [1]. The
incidence and prevalence of DN have shown upward
trends in recent years VSports. It is estimated that the number
of people living with diabetes will reach 693 million
globally by 2045 [2]. Sustained hyperglycemia will
cause extensive vascular damages to eyes, kidneys,
heart, and nerves. Approximately 40% of diabetes
patients have a tendency to develop DN [3].
Therefore, timely prevention and treatment of diabetes
and DN are of great significance. Long non-coding RNAs (lncRNAs) are transcripts
exceeding 200 nt long VSports app下载. Their structures are
similar to those of mRNAs. However, lncRNAs lack
cis-regulation ability and open reading frame [4].
Abnormal expression of lncRNA CASC11 has a relation
to human diseases. It is reported that IL-9-
induced activation of CASC11 accelerates the onset
of arteriosclerosis via mediating apoptosis and proliferation
in vascular smooth muscle cells [5][6][7]. During
tumor progression, CASC11 is capable of regulating
malignant phenotypes of tumor cells, indicating that
it may be a promising biomarker for tumors diagnosis
and prognostic evaluation [8]. However, the role of
CASC11 in DN was few reported. FoxO1 (forkhead transcription factor O1) exerts
regulatory effects on gene transcription, anti-oxidative
stress and metabolism [9]. Overexpression of FoxO1 is
able to alleviate damage of podocytes in DN [10]. By
high glucose induction, TGF-β1/Smad signaling drives
epithelia-mesenchymal transition in podocytes, manifesting
as downregulated nephrin (epithelial cell indicator)
and upregulated desmin (interstitial cell indicator). In
addition, TGF-β1/Smad signaling results in integrity destruction of glomerular filtration barrier and the occurrence
of proteinuria, thereafter triggering the occurrence
of DN [11] V体育官网. LncRNA ANCR promotes migration and
invasiveness in gastric cancer by regulating FoxO1 expression and suppressing M1 polarization of macrophages [12]. In a previous study, CTBP1-AS2 alleviates oxidative stress and inflammation induced by high-glucose
through miR-155-5p/FOXO1 axis in diabetic nephropathy [13]. However, the relationship between CASC11
and Foxo1 in DN were unclear. In our research, CASC11
was hypothesized to aggravate diabetic ne phro pathy via
targeting FoxO1, we aim to uncover the potential influences
of CASC11 and FoxO1 on DN progression by collecting
clinical samples of DN and generating in vitro HG
model in kidney mesangial cells. Our findings provide
novel ideas in health management of DN. Materials and methodsBaseline characteristics (VSports app下载)DN (n=50) and T2DM (n=50) patients were
respectively enrolled in the DN and control group, respectively. T2DM and DN were diagnosed based on
the WHO-1999 and WHO-2007 criteria [14][15]. The
diagnosis was confirmed by two professors. Candidates
with T1DM or other types of diabetes, abnormal liver
function, renal disease history, pregnancy, infectious
diseases, thyroid diseases and those unwilling to be
recruited were excluded. Venous blood samples were
collected from them in anticoagulant tubes. After storage
at 4°C for 30 min, it was centrifuged at 3,000 rpm
for 15 min. The upper layer serum was collected and
preserved at -80°C. The study was approved by the
Ethical Committee of Second Affiliated Hospital of
Fujian Medical University VSports手机版. Each participant provided the
signed written informed consent. V体育官网 - Cell culture and inductionKidney mesangial cells preserved in the liquid
nitrogen were recovered at 37°C. After centrifugation
at 1,500 rpm for 5 min, the cells were cultured in Ros -
well Park Memorial Institute 1640 (RPMI 1640) (pH
7. 2) (Beyotime, Shanghai, China) containing 10% fetal
bovine serum (FBS) (Beyotime, Shanghai, China), 100
μg/mL streptomycin and 100 μg/mL penicillin. They
were passaged until 80% confluence. Kidney mesangial
cells were induced in NG (normal glucose, 4 V体育安卓版. 0 mmol/L)
or HG (high glucose, 40. 0 mmol/L), respectively. Cell transfectionCells were cultivated in antibiotic-free medium
for cell transfection. 0. 5 μg plasmid (si-CASC11: 5’-
GCCCACATCAAGCCTTCAT-3’; si-FoxO1: 5’-CCAGAUGCCUAUACAAACA-
3’) and 1 μL of Lipofectamine 2000 kit (Sigma-Aldrich; Merck KGaA)
was respectively diluted in 50 μL of serum-free medium,
which were mixed together and applied for cell
transfection V体育ios版. Complete medium was replaced at 4–6
h, and transfected cells were cultivated another 36-h
for further experiments. Quantitative real-time polymerase chain reaction
(qRT-PCR)Total RNA was extracted using TRIzol® reagent
(Invitrogen; Carlsbad, CA, USA) according to manufacturer’s
protocol. Total RNA was reverse transcribed
into cDNA using the PrimeScript RT reagent kit
(Invitrogen; Carlsbad, CA, USA), according to the
manufacturer’s protocol. Levels were calculated using
the method of 2-ΔΔCt. Primers were synthesized by
XinFan Bio (Nanjing, China) VSports最新版本. Sequences of primers
used for qRT-PCR were as follows: CASC11: 5’-
CGACCCCAACACCTTCTTTG-3’ (forward) and 5’-
CTCACCCCTAAGTYCGCTGG-3’ (reverse); FoxO1:
5’-ATGGTCAAGAGCGTGCCC-3’ (forward) and 5’-
GATTGAGCATCCACCAAG-3’ (reverse); GAPDH: 5’-
ACTGCCACCCAGAAGACT-3’ (forward) and 5’-
GCTCAGTGTAGCCCAGGAT-3’ (reverse). Cell counting kit-8 (CCK-8)The 96-well plates were inoculated at 2×
103/well with 6 replicates in each group. 10 μL CCK-8
(Keygen, Nanjing, China) solution was added to each
well and incubated for another 2-h. After 1-h incubation
in the dark, absorbance at 450 nm was recorded
at the indicated time points using the CCK 8 kit V体育平台登录. Transwell assay50 μL Fibronectin (FN) was added to the lower
chamber and 100 μL matrix was added to the upper
chamber VSports注册入口. Cells (1×106) were added to the upper
chamber. The Transwell chamber was incubated in an
incubator for 24h and then removed and placed in a
24-well plate, 500 μL methanol was added and fixed
overnight at 4°C. After being washed with phosphate
buffered saline (PBS) for three times, images were
captured using an inverted microscope (Type:
AZ100, Nikon, Tokyo, Japan). Western blotTotal proteins in each group of cells were
extracted using RIPA (radioimmunoprecipitation) protein
lysate (Beyotime, Shanghai, China). The extracted
proteins were separated using a 12% sodium
dodecyl sulphate-polyvinylidene polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred on to
polyvinylidene fluoride membranes (Millipore, USA).
Subsequently, the membranes were immersed in 5%
skim milk for 2 hours. Primary antibodies were incubated
for overnight incubation at 4°C. The next day,
the membranes were incubated with horse radish peroxidase
(HRP)-labeled secondary antibody for 2 h. Bands were exposed using electrochemiluminescence (ECL) reagent V体育官网入口. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was served as the internal control. "V体育平台登录" Subcellular distribution analysis1×106 cells were lysed using Lysis Buffer. After
being centrifugated using a centrifuge, the supernatant
and precipitate were separated. Buffer SK and
absolute ethanol were then added to them, and cytoplasmic
RNA and nuclear RNA were extracted by column
centrifugation. Statistical analysisStatistical analysis were performed with the use
of SPSS (Version X; IBM, Armonk, NY, USA). Differences between two groups were analyzed by using
the Student’s t-test if they were normally distributed.
Diagnostic value of CASC11 in DN was evaluated by
depicting receiver operating characteristic (ROC)
curves. All the experiments were repeated triple
times. P<0.05 was considered as statistical significance. ResultsComparison of baseline characteristicsBy analyzing baseline characteristics between
groups, we found no significant differences in age,
gender, BMI, SBP, DBP, FBG, TC, HDL-C, LDL-C, TG
and HbA1c were identified, indicating the two groups
have a certain comparable value (P>0.05).   Table 1. Comparison of baseline characteristics. In particular,
values of Scr and BUN were observably higher in
DN group compared with those of control group
(P<0.05, Table 1). Increased serum level of CASC11 in DN patientsCompared with control group, serum level of
CASC11 was observably higher in DN group (Figure 1A).   ![]() Figure 1 Increased serum level of CASC11 in DN patients. (A) Serum level of CASC11 increased in DN patients compared
with that in controls; (B) ROC curves demonstrated the diagnostic potential of CASC11 in DN (AUC=0.872, P<0.001). Download as PPT slide
Download as image
Furthermore, ROC curves showed the diagnostic
potential of CASC11 in DN (AUC = 0.872, 95%CI =
0.805–0.939, P<0.001, Figure 1B). To uncover the role of CASC11 in the development
of DN, we tested the transfection efficacy of si-
CASC11 at first (Figure 2A).   ![]() Figure 2 CASC11 promoted proliferative and migratory abilities in kidney mesangial cells. (A) Transfection of si-CASC11 significantly
downregulated CASC11 in kidney mesangial cells; (B) CCK-8 assay showed inhibited proliferation in HG-induced kidney
mesangial cells with CASC11 knockdown; (C) Transwell assay showed inhibited migration in HG-induced kidney mesangial
cells with CASC11 knockdown. (magnification: 40×) Download as PPT slide
Download as image
Knockdown of CASC11
markedly weakened viability and migratory ability in
HG-induced kidney mesangial cells (Figure 2B, Figure 2C). It
is suggested that CASC11 was able to enhance proliferative
and migratory abilities in kidney mesangial
cells induced by high glucose. CASC11 inhibited FoxO1 levelExamination of the subcellular distribution
revealed that that CASC11 was predominantly
expressed in the nucleus (Figure 3A).   ![]() Figure 3 CASC11 inhibited FoxO1 level. (A) CASC11 mainly distributed in the nucleus; (B) Serum level of FoxO1 decreased
in DN patients compared with that in controls; (C) CASC11 was negatively correlated to FoxO1 (r=-0.3191, P=0.0024); (D)
FoxO1 was upregulated in HG-induced kidney mesangial cells with CASC11 knockdown. Download as PPT slide
Download as image
Subsequently,
serum level of FoxO1 in DN patients and T2DM
patients was detected. Serum level of FoxO1 was
much lower in DN patients compared with that of
T2DM patients, and it was negatively correlated to
CASC11 level (Figure 3B, Figure 3C). It is indicated that
FoxO1 may be involved in the progression of DN as
well. Furthermore, knockdown of CASC11 upregulated
FoxO1, which supports a negative interaction
between them (Figure 3D). VSports注册入口 - CASC11 regulated kidney mesangial cell functions
by FoxO1Transfection of pcDNA-CASC11 effectively
upregulated CASC11 in kidney mesangial cells
(Figure 4A).   ![]() Figure 4 CASC11 regulated kidney mesangial cell functions by FoxO1. (A) Transfection of pcDNA-CASC11 significantly
upregulated CASC11 in kidney mesangial cells; (B) Enhanced proliferation in HG-induced kidney mesangial cells overexpressing
CASC11 was reversed by co-overexpression of FoxO1; (C) Enhanced migration in HG-induced kidney mesangial cells overexpressing
CASC11 was reversed by co-overexpression of FoxO1 (magnification: 40×). Download as PPT slide
Download as image
Overexpression of CASC11 enhanced
viability and migratory cell number in HG-induced
kidney mesangial cells, and the increased trends were
reversed by co-overexpression of FoxO1 (Figure 4B,
Figure 4C). Hence, FoxO1 was involved in CASC11-regulated
functions of kidney mesangial cells. CASC11 negatively regulated FoxO1 level via the
TGF-β1/Smads signalingAs western blot analyses uncovered, protein levels
of TGF-β1 and Smads were observably upregu lated
in HG-induced kidney mesangial cells over expressing
CASC11 compared with those of HG-in duced controls. Interestingly, the upregulated levels of TGF-β1
and Smads were downregulated by co-overexpression
of FoxO1 (Figure 5A).   ![]() Figure 5 CASC11 negatively regulated FoxO1 level via the TGF-β1/Smads signaling. (A) Overexpression of FoxO1 reversed
the promotive effects of CASC11 on protein levels of TGF-β1 and Smads in kidney mesangial cells; (B) Knockdown of FoxO1
reversed the inhibitory effects of CASC11 on protein levels of TGF-β1 and Smads in kidney mesangial cells. Download as PPT slide
Download as image
As expected, downregulated
TGF-β1 and Smads in HG-induced kidney mesangial
cells with CASC11 knockdown were elevated by cosilence
of FoxO1 (Figure 5B). Therefore, the TGF-β1/
Smads signaling was responsible for the regulatory
effect of CASC11 on FoxO1 level. DiscussionIncreased glomerular filtration capacity and
microalbumin in the urine are the typical features of
DN. If not treated in time, aggravated lesions, including glomerular atrophy, basement membrane
thickening and extracellular matrix accumulation,
eventually lead to chronic renal insufficiency [16].
Timely intervention for DN will decrease the outflow
of microalbumin and thus prevent the development of
proteinuria phase. Once DN patients are deteriorated in the proteinuria phase, their kidney functions will be
severely impaired. Therefore, it is particularly important
to develop therapeutic strategies of DN in the
early phase [17]. LncRNAs are distributed in both cytoplasm and
nucleus. Nuclear lncRNAs act on chromatin and regulate
gene expressions, whereas cytoplasmic ones are
able to regulate gene translation by acting on mRNAs
[18]. Potential influences of lncRNAs on the development
of DN have been identified. It is reported that
lncRNA MALAT1 is upregulated in the in vivo T2DM
model. Knockdown of MALAT1 remarkably alleviates
T2DM-induced microvascular dysfunction (i.e. diabetic
retinopathy) [19]. Gupta et al. [20] showed that
expression levels of inflammatory factors (IL-6, IL-1β
and TNF-α) increase at transcriptional and translational
levels along with the upregulation of MALAT1
in HG-induced mouse renal endothelial cells.
LncRNA CASC11 is located on chromosome
8q24.21 with 872 bp in transcripts, which is also
known as cancer susceptibility candidate 11 or
LINC00990 [21]. Zhang et al. [22] suggested that
CASC11 is upregulated in colorectal cancer specimens.
By targeting hnRNP-K, CASC11 drives malignant
phenotypes in colorectal cancer cells via activating
the WNT / β-catenin signaling. Our study
demonstrated that CASC11 was highly expressed in
the serum of DN patients, suggesting a certain diagnostic
potential in DN. Moreover, CASC11 could
stimulate proliferative and migratory abilities in kidney
mesangial cells, and upregulate protein levels of TGF-β1
and Smads. FoxO1 is a vital regulator in glycolipid metabolism,
oxidative stress and cell functions [23]. Recent
studies have uncovered that some Fox members,
such as FoxM1, FoxC2 and FoxF2, are capable of
intervening EMT [24][25]. The differentiation of
FoxO1 knockout mouse embryos is terminated in embryonic stage, indicating a relation between
FoxO1 and cell differentiation in the pathological
state [25]. The interaction between Smad protein and
FoxO1 via the TGF-β signaling initiates the growth
suppressor gene p21Cip1 [26]. In our experiment,
FoxO1 was lowly expressed in the serum of DN
patients, and negatively correlated to CASC11 level.
Over-expression of FoxO1 reversed the modulatory
functions of CASC11 on proliferative and migratory
abilities in kidney mesangial cells, and the increase in
protein levels of TGF-β1 and Smads. As a result,
FoxO1 was responsible for CASC11 in regulating
functions of kidney mesangial cells, and the TGF-β1
/ Smads signaling. Numerous tissue-specific lncRNAs have been
found with the extensive application of sequencing
and lncRNA microarray analyses. They are promising
biomarkers for prevention, diagnosis and treatment of
human diseases. Our findings suggested that lncRNA
CASC11 could be utilized as a novel biomarker for
DN. ConclusionsThrough activating the TGF-β1/Smads signaling,
CASC11 inhibits FoxO1 expression and thus
induces aggravation of DN. V体育安卓版 - DodatakFundingNatural Science Foundation of Fujian Province
(2021J01250). Conflict of interest statementAll the authors declare that they have no conflict
of interest in this work.
References
1. | Torok B, Toth I, Halmagyi G, Roth E. The donor kidney: III. Angio-architecture and function of the reimplanted kidney. Acta Chir Acad Sci Hung. 1978;19(2):137-144. | 2. | Cho NH, Shaw JE, Karuranga S, Huang Y, Da RFJ, Ohlrogge AW. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pr. 2018;138:271-281. [Crossref] | 3. | Dewanjee S, Bhattacharjee N. MicroRNA: A new generation therapeutic target in diabetic nephropathy. Biochem Pharmacol. 2018;155:32-47. [Crossref] | 4. | Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47-62. [Crossref] | 5. | Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S, Pearson JV. Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study. Diabetes. 2007;56(4):975-983. [Crossref] | 6. | Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK. Variants in the Plasmacytoma Variant Translocation Gene (PVT1) Are Associated With End-Stage Renal Disease Attributed to Type 1 Diabetes. Diabetes. 2007;56(12):3027-3032. [Crossref] | 7. | Baggaley KH, Fears R, Hindley RM, Morgan B, Murrell E, Thorne DE. Hypolipidemic analogs of ethyl 4-benzyloxybenzoate. J Med Chem. 1977;20(11):1388-1393. [Crossref] | 8. | Balkany TJ, Berman SA, Watson WJ. Sterile Preparation of the External Auditory Canal with Povidone-Iodine. Otolaryngol Head Neck Surg. 1979;87(2):258-260. [Crossref] | 9. | Ponugoti B, Dong G, Graves DT. Role of Forkhead Transcription Factors in Diabetes-Induced Oxidative Stress. Exp Diabetes Res. 2012;2012:939751. [Crossref] [PubMed] [PMC] | 10. | Guo F, Zhang Y, Wang Q, Ren L, Zhou Y, Ma X. Effects of FoxO1 on podocyte injury in diabetic rats. Biochem Bioph Res Co. 2015;466(2):260-266. [Crossref] | 11. | Hills CE, Squires PE. TGF-beta1-Induced Epithelial-to-mesenchymal Transition and Therapeutic Intervention in Diabetic Nephropathy. Am J Nephrol. 2010;31(1):68-74. [Crossref] | 12. | Xie C, Guo Y, Lou S. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization. Digest Dis Sci. 2020;65(10):2863-2872. [Crossref] | 13. | Hosseini M, Nezhadali M, Hedayati M. Association of vaspin rs2236242 gene polymorphism with serum vaspin level, insulin resistance and diabetes in an Iranian diabetic/pre-diabetic population. J Med Biochem. 2021;40(1):33-40. [Crossref] [PubMed] [PMC] | 14. | Goedegebure E, Koning SH, Hoogenberg K, Korteweg FJ, Lutgers HL, Diekman M. Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: A multicentre retrospective cohort study. BMC Pregnancy Childb. 2018;18(1):152. [Crossref] [PubMed] [PMC] | 15. | Klebe B, Farmer C, Cooley R, de Lusignan S, Middleton R, O'Donoghue D. Kidney disease management in UK primary care: Guidelines, incentives and Information Technology. Fam Pract. 2007;24(4):330-335. [Crossref] | 16. | Ni WJ, Tang LQ, Wei W. Research progress in signalling pathway in diabetic nephropathy. Diabetes-Metab Res. 2015;31(3):221-233. [Crossref] | 17. | Sidaway P. Diabetic nephropathy: Heparanase mediates renal injury. Nat Rev Nephrol. 2014;10(9):483. | 18. | Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10(6):924-933. [Crossref] [PubMed] [PMC] | 19. | Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 2014;5:e1506. [Crossref] [PubMed] [PMC] | 20. | Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071-1076. [Crossref] [PubMed] [PMC] | 21. | Stierle G. Problems concerning the seriously ill and dying child. Krankenpflege (Frankf). 1977;31(10):347-350. | 22. | Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y, Zhang F. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/beta-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett. 2016;376(1):62-73. [Crossref] | 23. | Wu L, Zhang Y, Ma X, Zhang N, Qin G. The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Mol Biol Rep. 2012;39(9):9085-9093. [Crossref] | 24. | Cai J, Tian AX, Wang QS, Kong PZ, Du X, Li XQ. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer. Cancer Lett. 2015;367(2):129-137. [Crossref] | 25. | Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M, Guo YH. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncol Rep. 2014;31(6):2660-2668. [Crossref] | 26. | Seoane J, Le HV, Shen L, Anderson SA, Massagué J. Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation. Cell. 2004;117(2):211-223. [Crossref] |
08/02/202310/01/202325/08/2023
|
|
|
Reference
|
|
Baggaley, K.H., Fears, R., Hindley, R.M., Morgan, B., Murrell, E., Thorne, D.E. (1977) Hypolipidemic analogs of ethyl 4-benzyloxybenzoate. J Med Chem, 20(11): 1388-1393
|
|
Balkany, T.J., Berman, S.A., Watson, W.J. (1979) Sterile Preparation of the External Auditory Canal with Povidone-Iodine. Otolaryngol Head Neck Surg, 87(2): 258-260
|
|
Cai, J., Tian, A.X., Wang, Q.S., Kong, P.Z., Du, X., Li, X.Q., Feng, Y. (2015) FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer. Cancer Lett, 367(2): 129-137
|
1
|
Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da R.F.J., Ohlrogge, A.W., et al. (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 138: 271-281
|
|
Dewanjee, S., Bhattacharjee, N. (2018) MicroRNA: A new generation therapeutic target in diabetic nephropathy. Biochem Pharmacol, 155: 32-47
|
|
Goedegebure, E.A.R., Koning, S.H., Hoogenberg, K., Korteweg, F.J., Lutgers, H.L., Diekman, M.J.M., Stekkinger, E., van den Berg, P.P., Zwart, J.J. (2018) Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: A multicentre retrospective cohort study. BMC Pregnancy Childbirth, 18(1): 152
|
|
Guo, F., Zhang, Y., Wang, Q., Ren, L., Zhou, Y., Ma, X., Wu, L., Qin, G. (2015) Effects of FoxO1 on podocyte injury in diabetic rats. Biochem Biophys Res Commun, 466(2): 260-266
|
|
Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., Tsai, M., Hung, T., Argani, P., Rinn, J.L., Wang, Y.C., Brzoska, P., Kong, B., Li, R., West, R.B., van de Vijver, M.J. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464(7291): 1071-1076
|
|
Hanson, R.L., Craig, D.W., Millis, M.P., Yeatts, K.A., Kobes, S., Pearson, J.V., Lee, A.M., Knowler, W.C., Nelson, R.G., Wolford, J.K. (2007) Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study. Diabetes, 56(4): 975-983
|
|
Hills, C.E., Squires, P.E. (2010) TGF-b1-Induced Epithelial-to-Mesenchymal Transition and Therapeutic Intervention in Diabetic Nephropathy. Am J Nephrol, 31(1): 68-74
|
1
|
Hosseini, M., Nezhadali, M., Hedayati, M. (2021) Association of vaspin rs2236242 gene polymorphism with serum vaspin level, insulin resistance and diabetes in an Iranian diabetic/pre-diabetic population. J Med Biochem, vol. 40, br. 1, str. 33-40
|
|
Klebe, B., Farmer, C., Cooley, R., de Lusignan, S., Middleton, R., O'Donoghue, D., New, J., Stevens, P. (2007) Kidney disease management in UK primary care: Guidelines, incentives and Information Technology. Fam Pract, 24(4): 330-335
|
|
Kong, F.F., Qu, Z.Q., Yuan, H.H., Wang, J.Y., Zhao, M., Guo, Y.H., Shi, J., Gong, X., Zhu, Y., Liu, F., Zhang, W., Jiang, B. (2014) Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncol Rep, 31(6): 2660-2668
|
|
Liu, J.Y., Yao, J., Li, X.M., Song, Y.C., Wang, X.Q., Li, Y.J., et al. (2014) Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death & Disease, 5(10): e1506
|
|
Ma, L., Bajic, V.B., Zhang, Z. (2013) On the classification of long non-coding RNAs. RNA Biol, 10(6): 924-933
|
|
Millis, M.P., Bowen, D., Kingsley, C., Watanabe, R.M., Wolford, J.K. (2007) Variants in the Plasmacytoma Variant Translocation Gene (PVT1) Are Associated With End-Stage Renal Disease Attributed to Type 1 Diabetes. Diabetes, 56(12): 3027-3032
|
|
Ni, W.J., Tang, L.Q., Wei, W. (2015) Research progress in signalling pathway in diabetic nephropathy. Diabetes Metab Res Rev, 31(3): 221-233
|
|
Ponugoti, B., Dong, G., Graves, D.T. (2012) Role of Forkhead Transcription Factors in Diabetes-Induced Oxidative Stress. Exp Diabetes Res, 939751
|
|
Quinn, J.J., Chang, H.Y. (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet, 17(1): 47-62
|
|
Seoane, J., Le, H.V., Shen, L., Anderson, S.A., Massagué, J. (2004) Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation. Cell, 117(2): 211-223
|
|
Sidaway, P. (2014) Diabetic nephropathy: Heparanase mediates renal injury. Nat Rev Nephrol, 10(9): 483
|
|
Stierle, G. (1977) Problems concerning the seriously ill and dying child. Krankenpflege, 31(10): 347-350
|
|
Torok, B., Toth, I., Halmagyi, G., Roth, E. (1978) The donor kidney: III. Angio-architecture and function of the reimplanted kidney. Acta Chir Acad Sci Hung, 19(2): 137-144
|
|
Wu, L., Zhang, Y., Ma, X., Zhang, N., Qin, G. (2012) The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Mol Biol Rep, 39(9): 9085-9093
|
|
Xie, C., Guo, Y., Lou, S. (2020) LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization. Dig Dis Sci, 65(10): 2863-2872
|
|
Zhang, Z., Zhou, C., Chang, Y., Zhang, Z., Hu, Y., Zhang, F., Lu, Y., Zheng, L., Zhang, W., Li, X., Li, X. (2016) Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/b-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett, 376(1): 62-73
|
|
|
|